Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
100%
Tuberculosis Patients
51%
Indonesia
50%
Surabaya
40%
Drug-resistant Tuberculosis (DR-TB)
39%
Indonesian
36%
Type 2 Diabetes Mellitus (T2DM)
36%
Medication Adherence
33%
Exclusion Criteria
32%
Bedaquiline
30%
Antibiotics
29%
Medical Records
28%
Glycemic Control
26%
Type 2 Diabetic Patients
25%
Interleukin-6
25%
QTc Interval
23%
Universitas Airlangga
22%
Clinical Outcomes
22%
Rifampicin-resistant Tuberculosis (RR-TB)
22%
Osteoarthritis
22%
Teaching Hospital
21%
Diabetes Mellitus
21%
Risk Factors
21%
QTc Prolongation
21%
Drug-related Problems
20%
Blood Glucose
19%
Matrix metalloproteinase-9 (MMP-9)
19%
Antibiotic Use
19%
COVID-19 Patients
19%
Body Mass Index
18%
Anticoagulants
18%
Insulin Therapy
18%
Chronic Kidney Disease
17%
Geriatric Patients
17%
Pediatric Patients
17%
Drug Use
17%
Atorvastatin
16%
C-reactive Protein
16%
Delamanid
16%
Lopinavir
16%
Stress Ulcer Prophylaxis
16%
Scoping Review
16%
Fluvoxamine
16%
Quercetin
16%
Prophylactic Antibiotics
16%
Glutaraldehyde
16%
General Hospital
15%
Quality of Life
15%
Azithromycin
15%
Adverse Drug Reaction
15%
Diclofenac Sodium
14%
Moxifloxacin
14%
Chemotherapy
14%
Monotherapy
14%
Adverse Effects
14%
Enoxaparin
13%
Drug Combination
13%
Warfarin
13%
Short-term Treatment
13%
Meta-analysis
13%
MRNA Expression
13%
Hospitalization
13%
Morphine
13%
Surgical Site Infection
13%
Inflammatory Markers
12%
Stress-induced Gastric Ulcer
12%
Phenytoin
12%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
12%
AIDS/HIV
12%
Inflammatory Cytokines
12%
Mortality Prediction
12%
Constipation
12%
West Java Indonesia
11%
Cancer Patients
11%
Heart Failure Patients
11%
Diuretics
11%
Bronchodilator
11%
Length of Stay
11%
Andrographolide
11%
Knee Osteoarthritis
11%
Lipid Profile
11%
Non-Hodgkin Lymphoma
11%
Diabetes Distress
11%
Neuroimaging Abnormalities
11%
Lung Imaging
11%
Burn Patients
11%
Cost Analysis
11%
Potentially Inappropriate Medication
11%
Public Hospitals
11%
Tumor Lysis Syndrome
11%
Kidney Function
11%
Primary Healthcare Centers
11%
Self-medication
11%
Nicotine
11%
Aquaporin-3 (AQP3)
11%
Hydroxychloroquine
11%
Hepatic Cirrhosis
11%
Corrected QT Interval
11%
Multidrug-resistant Tuberculosis (MDR-TB)
11%
Children with Type 1 Diabetes
11%
Nursing and Health Professions
COVID-19
89%
Adherence
51%
Diabetes Mellitus
37%
Medication Compliance
33%
Maturity Onset Diabetes of the Young
33%
Cross-Sectional Study
33%
Glycemic Control
33%
Outpatient
28%
Glucose Blood Level
26%
Patient with Type 2 Diabetes
26%
Education
24%
Insulin Treatment
24%
Chemotherapy
23%
Clinical Outcome
22%
Insulin
21%
Teaching Hospital
19%
Antimicrobial Agent
19%
Gelatinase B
17%
Systematic Review
16%
Acute Heart Failure
16%
Prevalence
16%
Treatment Outcome
14%
Biological Marker
14%
Outpatient Department
13%
Osteoarthritis
13%
Malignant Neoplasm
13%
Anticoagulant Agent
12%
Diseases
12%
Human Immunodeficiency Virus
12%
Meta Analysis
11%
Gerontology
11%
Public Hospital
11%
Accident Prevention
11%
Insulin Dependent Diabetes Mellitus
11%
Arthralgia
11%
Knee Osteoarthritis
11%
Imaging
11%
Medical Record
10%
Length of Stay
10%
Sodium
10%
Adverse Effect
9%
Efficacy
9%
Surgical Infection
9%
Patient Compliance
9%
Hemoglobin A1c
9%
Body Mass
9%
Self Medication
9%
D Dimer
9%
Furosemide
9%
Sodium Intake
8%
Glycosylated Hemoglobin
8%
Monotherapy
8%
General Hospital
8%
Practice Guideline
8%
Interleukin 6
8%
Quality of Life
8%
Short Acting Insulin
8%
Infection
7%
Blood Pressure
7%
Physical Activity
7%
Pill
7%
Youth
7%
Congestive Heart Failure
7%
Elderly Patient
7%
Cardiovascular Disease
7%
Mortality Rate
6%
Thorax Radiography
6%
Influencing Factor
6%
Interleukin 10
6%
Medication Error
6%
Drug Use
6%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
6%
Tissue Inhibitor of Metalloproteinase
6%
Patient with Diabetes
6%
Asthma
6%
Chronic Kidney Failure
6%
Atorvastatin
6%
Acquired Immune Deficiency Syndrome
6%
Pneumonia
6%
Blood Level
6%
Cost Benefit Analysis
6%
National Health Insurance
6%
Case-Control Study
6%
Emergency Ward
6%
Cohort Analysis
6%
Antidiabetic Agent
6%
Glimepiride
5%
Statin (Protein)
5%
Urologic Surgery
5%
Factor A
5%
Fondaparinux
5%
Warfarin
5%
Potentially Inappropriate Medication
5%
Phenytoin
5%
Beta Adrenergic Receptor Blocking Agent
5%
Nasopharynx Cancer
5%
Dual Antiplatelet Therapy
5%
Parenteral Nutrition
5%
Intensive Care Unit
5%
Narcotic Analgesic Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
40%
Retrospective Study
37%
Antimicrobial Agent
30%
Antibiotics
28%
Interleukin 6
24%
Chronic Kidney Failure
24%
Drug Resistant Tuberculosis
22%
Observational Study
22%
Adverse Drug Reaction
20%
Atorvastatin
18%
Maturity Onset Diabetes of the Young
17%
Prevalence
17%
Side Effect
17%
Stress Ulcer
16%
Dyslipidemia
16%
Lopinavir Plus Ritonavir
16%
Glutaraldehyde
16%
Insulin
16%
Diclofenac
16%
Gelatin
16%
Hypertension
16%
Cross-Sectional Study
15%
Azithromycin
15%
Hemodialysis
14%
Anticoagulant Agent
13%
Glucose
13%
Morphine
13%
Adverse Effect
12%
Enoxaparin
12%
Combination Drug
12%
Chitosan
12%
Monotherapy
12%
Lipid
12%
Phenytoin
12%
Constipation
12%
Polypharmacy
12%
HIV
11%
Clinical Study
11%
Coronavirinae
11%
Bronchodilating Agent
11%
Chemotherapy Regimens
11%
Inflammation
11%
Fluvoxamine
11%
Bedaquiline
11%
Rifampicin
11%
Quercetin
11%
Tumor Lysis Syndrome
11%
Coronary Artery Disease
11%
Chronic Obstructive Lung Disease
11%
Hydroxychloroquine
11%
Statin (Protein)
11%
Acute Heart Failure
11%
Nicotine
11%
Clinical Pharmacy
11%
Self-Medication
11%
Cardiovascular Disease
10%
Immunoglobulin A
10%
Messenger RNA
10%
Surgical Infection
9%
Polyethylene Glycol
9%
Acetylsalicylic Acid
9%
D Dimer
9%
Hydroxyapatite
9%
Antiplatelet
9%
Cerebrovascular Accident
9%
Stomach Ulcer
9%
Brain Ischemia
8%
Pharmacokinetics
8%
Ticagrelor
8%
Osteoarthritis
8%
Virus
8%
Nonhodgkin Lymphoma
8%
Chondroitin Sulfate
8%
Drug Utilization
8%
Captopril
8%
Drug Interaction
8%
Cigarette Smoke
7%
Diabetes Mellitus
7%
Infection
7%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
7%
Essential Medicines
7%
Gelatinase B
7%
Antihypertensive Agent
7%
Asthma
7%
Doxycycline
7%
Allopurinol
7%
Paracetamol
7%
Amoxicillin
7%
Malignant Neoplasm
7%
Cytokine
7%
Sepsis
7%
Warfarin
6%
Fondaparinux
6%
Brain Injury
6%
Treatment Group
6%
Tumor Necrosis Factor
6%
Randomized Controlled Trial
6%
Tuberculosis
6%
Anti-Inflammatory Drug
6%
Receptor
6%